TMCnet News
Research and Markets: Global Cervical Cancer Diagnostic Tests Market 2014-2018 with Abbott Laboratories, Becton Dickinson, Hologic, Qiagen, Quest Diagnostics & Roche Diagnostics DominatingResearch and Markets (http://www.researchandmarkets.com/research/3d2f33/global_cervical) has announced the addition of the "Global Cervical Cancer Diagnostic Tests Market 2014-2018" report to their offering. The Global Cervical Cancer Diagnostic Tests market to grow at a CAGR of 10.8% over the period 2013-2018. The development of new diagnostic technologies is one key trend emerging in this market. Various organizations and companies are focusing on R&D to discover and identify new biomarkers to help in the accurate diagnosis of cervical cancer. According to the report, increase in incidence of smoking and increased incidence of HPV infection among women are the major factors propelling the growth of the maret. Smoking compromises the immune system and leads to decreased immunity. HPV infections are subclinical or asymptomatic, and no physical symptoms are observed in an individual. Hence, individuals may not be aware of the infection. Further, the report states that low public awareness of cervical cancer owing to lower socio-economic status of women in many developed and developing countries is a major challenge. Awareness about cervical cancer and educating the population about the disease and its effects can help in its prevention and early detection. To calculate the market size, the report considers the revenue generated from the sales of the following diagnostic test kits and instruments used to diagnose cervical cancer:
In addition, the report includes the type of method used to identify cervical cancer:
Technological types used in cervical cancer identification are also discussed in this report: Key Vendors
For more information visit http://www.researchandmarkets.com/research/3d2f33/global_cervical.
|
